Literature DB >> 31574313

Performance of Simple Fibrosis Scores in Nonobese Patients With Nonalcoholic Fatty Liver Disease.

Charmaine Fu1, Janae Wentong Wai1, Nik Raihan Nik Mustapha2, Marie Irles3, Grace Lai-Hung Wong4, Sanjiv Mahadeva5, Sarah Shili3, Anthony Wing-Hung Chan6, Wassil Merrouche3, Henry Lik-Yuen Chan4, Juliette Foucher3, Brigitte Le Bail7, Vincent Wai-Sun Wong4, Wah Kheong Chan8, Victor de Lédinghen9.   

Abstract

Because only a minority of patients with nonalcoholic fatty liver disease (NAFLD) have advanced fibrosis and would eventually develop liver-related complications, current guidelines recommend initial assessment with noninvasive tests of fibrosis.1-3 Most previous studies focused on overweight and obese patients. Despite a strong association between obesity and NAFLD, 3%-30% of people with relatively normal body mass index (BMI) may still have NAFLD.4,5 Hence, this study aims to evaluate the performance of the common noninvasive tests in non-obese (BMI <25 kg/m2) and obese (BMI ≥25 kg/m2) NAFLD patients.
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 31574313     DOI: 10.1016/j.cgh.2019.09.027

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  3 in total

1.  The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.

Authors:  Mohammed Eslam; Shiv K Sarin; Vincent Wai-Sun Wong; Jian-Gao Fan; Takumi Kawaguchi; Sang Hoon Ahn; Ming-Hua Zheng; Gamal Shiha; Yusuf Yilmaz; Rino Gani; Shahinul Alam; Yock Young Dan; Jia-Horng Kao; Saeed Hamid; Ian Homer Cua; Wah-Kheong Chan; Diana Payawal; Soek-Siam Tan; Tawesak Tanwandee; Leon A Adams; Manoj Kumar; Masao Omata; Jacob George
Journal:  Hepatol Int       Date:  2020-10-01       Impact factor: 6.047

2.  AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review.

Authors:  Michelle T Long; Mazen Noureddin; Joseph K Lim
Journal:  Gastroenterology       Date:  2022-07-14       Impact factor: 33.883

Review 3.  Confounding factors of non-invasive tests for nonalcoholic fatty liver disease.

Authors:  Janae Wentong Wai; Charmaine Fu; Vincent Wai-Sun Wong
Journal:  J Gastroenterol       Date:  2020-05-25       Impact factor: 7.527

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.